Researchers in Göttingen, Germany, have elucidated the structure and function of otoferlin, a protein that plays a crucial role in the hearing process. Loss of otoferlin or impairment of its function causes a frequent form of congenital deafness. The results, published in the journal Science Advances, mark a milestone after more than two decades of research on otoferlin at Göttingen Campus and contribute to optimizing the first gene therapies for the treatment of deafness.
This article was originally published on MedicalXpress.com
